Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | MGAM | O43451 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | SI | P14410 | 1/20 | 0.42 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.42 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.42 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.38 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.35 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | CAD | P27708 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14016338 | 1.00 | ALDH1A1 (0.46) | ALDH1A1TRPA1LMNAHSD17B10ALOX15 | |
| SCHEMBL18397555 | 0.91 | ALDH1A1 (0.41) | ALDH1A1TRPA1LMNAHSD17B10ALOX15 | |
| SCHEMBL1370661 | 0.88 | ALDH1A1 (0.40) | ALDH1A1TRPA1LMNAHSD17B10ALOX15 | |
| SCHEMBL30520135 | 0.88 | ALDH1A1 (0.40) | ALDH1A1TRPA1LMNAHSD17B10ALOX15 | |
| SCHEMBL20328792 | 0.86 | ALDH1A1 (0.39) | ALDH1A1TRPA1LMNAHSD17B10ALOX15 | |
| SCHEMBL12539120 | 0.86 | CYP3A4 (0.45) | ALDH1A1TRPA1LMNAHSD17B10ALOX15 | |
| SCHEMBL20332953 | 0.86 | CYP3A4 (0.45) | ALDH1A1TRPA1LMNAHSD17B10ALOX15 | |
| SCHEMBL25626564 | 0.84 | CPB2 (0.40) | ALDH1A1TRPA1LMNAHSD17B10ALOX15 | |
| SCHEMBL189345 | 0.84 | — | — | |
| SCHEMBL36999 | 0.84 | ZDHHC7 (0.47) | ALDH1A1TRPA1LMNAHSD17B10ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113603683-B | Substituted phenyl oxazolidinones for antimicrobial treatment | 结核病药物开发全球联盟公司 | 2024-06-14 | — | — | CN | disclosed |
| US-11964949-B2 | Substituted phenyloxazolidinones for antimicrobial therapy | THE GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT, INC. (US) | 2024-04-23 | — | — | US | disclosed |
| US-11649244-B2 | Method for synthesizing diaza-bridged compound and a diaza-bridged compound | LinkChem Co., Ltd., Shanghai (CN) | 2023-05-16 | — | — | US | disclosed |
| US-11649244-B2 | Method for synthesizing diaza-bridged compound and a diaza-bridged compound | LinkChem Co., Ltd., Shanghai (CN) | 2023-05-16 | — | — | US | disclosed |
| US-11649244-B2 | Method for synthesizing diaza-bridged compound and a diaza-bridged compound | LinkChem Co., Ltd., Shanghai (CN) | 2023-05-16 | — | — | US | disclosed |
| CN-113999152-B | Synthesis method of cis-1-benzyl-2, 4-dialkoxycarbonyl azetidine | 上海凌富药物研究有限公司 | 2023-05-09 | — | — | CN | disclosed |
| CN-113999239-B | Method for synthesizing diaza-bridge compound | 上海凌富药物研究有限公司 | 2022-11-11 | — | — | CN | disclosed |
| US-20220119397-A1 | Method for Synthesizing Diaza-Bridged Compound and a Diaza-Bridged Compound | LINKCHEM TECHNOLOGY CO., LTD. (CN) | 2022-04-21 | — | — | US | disclosed |
| CN-113999152-A | Synthesis method of cis-1-benzyl-2, 4-dialkoxy carbonyl azetidine | 上海凌富药物研究有限公司 | 2022-02-01 | — | — | CN | disclosed |
| CN-113999239-A | Method for synthesizing diaza-bridge compound | 上海凌富药物研究有限公司 | 2022-02-01 | — | — | CN | disclosed |
| EP-1714993-A1 | THERMOPLASTIC ELASTOMER COMPOSITION AND MOLDED ARTICLE | KANEKA CORPORATION (JP) | 2006-10-25 | — | — | EP | disclosed |
| EP-1714992-A1 | THERMOPLASTIC ELASTOMER COMPOSITION AND MOLDED ARTICLE | Kaneka Medix Corporation (JP) | 2006-10-25 | — | — | EP | disclosed |
| EP-1669406-A1 | THERMOPLASTIC ELASTOMER COMPOSITION | KANEKA CORPORATION (JP) | 2006-06-14 | — | — | EP | disclosed |
| US-20050272865-A1 | Block copolymer | KANEKA CORPORATION | 2005-12-08 | — | — | US | disclosed |
| US-20050234199-A1 | Acrylic block copolymer and thermoplastic resin composition | KANEKA CORPORATION (JP) | 2005-10-20 | — | — | US | disclosed |
| EP-1541595-A1 | ACRYLIC BLOCK COPOLYMER AND THERMOPLASTIC RESIN COMPOSITION | KANEKA CORPORATION (JP) | 2005-06-15 | — | — | EP | disclosed |
| US-20050085592-A1 | Block copolymer | KANEKA CORPORATION (JP) | 2005-04-21 | — | — | US | disclosed |
| EP-1475397-A1 | BLOCK COPOLYMER | KANEKA CORPORATION (JP) | 2004-11-10 | — | — | EP | disclosed |
| US-20040147674-A1 | Thermoplastic resin composition | KANEKA CORPORATION (JP) | 2004-07-29 | — | — | US | disclosed |
| EP-1398353-A1 | THERMOPLASTIC RESIN COMPOSITION | Kaneka Corporation (JP) | 2004-03-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11964949-B2 | Substituted phenyloxazolidinones for antimicrobial therapy | THPO, TBCD, OXA1L | ALDH1A1 1310/4885TRPA1 2957/4885LMNA 3725/4885 |
| US-20220119397-A1 | Method for Synthesizing Diaza-Bridged Compound and a Diaza-Bridged Compound | DGAT2, NOS2, ABL1 | ALDH1A1 1040/4885TRPA1 76/4885LMNA 3062/4885 |
| US-11649244-B2 | Method for synthesizing diaza-bridged compound and a diaza-bridged compound | DGAT2, NOS2, ABL1 | ALDH1A1 1040/4885TRPA1 76/4885LMNA 3062/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.